Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Marantz

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Treatment Reports|November 1, 1986
Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancerH Muro, L R Acuña, A Castagnari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracilP V Woolley, M J Ayoob, F P Smith, et al.
Cancer Treatment Reports|April 1, 1987
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health OrganizationJ D Ahlgren, F P Smith, E Cazap, et al.
Seminars in Oncology|August 18, 2001
Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancerA Marantz, S Jovtis, E Almira, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Treatment Reports|November 1, 1986
Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancerH Muro, L R Acuña, A Castagnari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracilP V Woolley, M J Ayoob, F P Smith, et al.
Cancer Treatment Reports|April 1, 1987
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health OrganizationJ D Ahlgren, F P Smith, E Cazap, et al.
Seminars in Oncology|August 18, 2001
Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancerA Marantz, S Jovtis, E Almira, et al.
Pageof 3